Immunohistochemistry (IHC) Market Analysis and Forecast to 2032: By Product (Antibodies, Reagents, Equipment, Kits), Application (Diagnostics, Research, Forensic), End User (Hospitals and Diagnostic Labs, Academic & Research Institutes, and Others), and Region

Immunohistochemistry (IHC) is a technique used to detect specific proteins in cells of a tissue section by exploiting the principle of antibodies binding to antigens in biological tissues. IHC makes it possible to visualize the distribution and localization of specific proteins in cells and tissues.

The Immunohistochemistry IHC Market size was USD 2.6 Billion in 2022 and is anticipated to reach USD 45.6 Billion in 2032, growing at a rate of 6.0% from 2023 to 2032.

Key Trends

The key trends in immunohistochemistry (IHC) technology are the development of more sensitive and specific antibodies, the use of new detection methods, and the automation of IHC procedures.

The development of more sensitive and specific antibodies has allowed for the detection of lower levels of antigens and the identification of more specific cell types.

New detection methods, such as fluorescence microscopy, have increased the sensitivity of IHC procedures. Automation of IHC procedures has reduced the time and labor required for these procedures.

Key Drivers

The key drivers of the Immunohistochemistry (IHC) market are the rising incidence of cancer, the growing aging population, and increasing investment by public and private organizations.

The rising incidence of cancer is the major factor driving the growth of the IHC market. The rising incidence of cancer is attributable to the growing aging population and the associated risk factors, such as obesity, sedentary lifestyle, and tobacco use.

The growing aging population is another key driver of the IHC market. The aging population is more susceptible to chronic diseases, such as cancer.

The increasing investment by public and private organizations is another key driver of the IHC market. Governments of various countries are investing in cancer research and treatment.

Restraints & Challenges

One of the key restraints in the immunohistochemistry market is the lack of skilled personnel. This is because the procedure is complex and requires skilled personnel to perform it.

There is also a lack of standardization in the procedure, which makes it difficult to compare results across different laboratories.

Another challenge in the immunohistochemistry market is the high cost of the procedure. This is because it requires specialized equipment and reagents, which can be expensive.

Market Segments

The Immunohistochemistry (IHC) Market is segmented by product, application, end-user and region. By product the market is divided into antibodies, reagents, equipment and kits. Based on application it is segmented into diagnostics, research and forensic. On the basis of end-user it is bifurcated into hospitals, diagnostic labs and academia. Region-wise the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World.

Key Players

The Immunohistochemistry (IHC) Market includes players such as F. Hoffman-La Roche AG, Danaher Corporation, Agilent Technologies, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Abcam plc, Dickinson and Company, PerkinElmer, Inc. and Takara Bio, Inc.

 

Why GIS?

Table of Contents

Chapter 1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market

Chapter 3. Immunohistochemistry (IHC) Market Outlook
3.1. Immunohistochemistry (IHC) Market segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. PESTLE Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or Retailers
3.6. Impact of the Russia and Ukraine War on the Immunohistochemistry (IHC) Market

Chapter 4. Economic Impact of COVID-19
4.1. Overall Impact of COVID-19
4.2. Impact of COVID On the Immunohistochemistry (IHC) Market
4.3. Economic Impact Analysis

Chapter 5. Immunohistochemistry (IHC) Market by Product
5.1. Market Overview
5.2. Antibodies
5.2.1. Market Size and Forecast, 2022-2032 ($Million)
5.2.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
5.3. Reagents
5.3.1. Market Size and Forecast, 2022-2032 ($Million)
5.3.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
5.4. Equipment
5.4.1. Market Size and Forecast, 2022-2032 ($Million)
5.4.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
5.5. Equipment
5.5.1. Market Size and Forecast, 2022-2032 ($Million)
5.5.2. Market Size and Forecast, by Region, 2022-2032 ($Million)

Chapter 6. Immunohistochemistry (IHC) Market by Application
6.1. Market Overview
6.2. Diagnostic application
6.2.1. Market Size and Forecast, 2022-2032 ($Million)
6.2.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
6.3. Research application
6.3.1. Market Size and Forecast, 2022-2032 ($Million)
6.3.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
6.4. Forensic application
6.4.1. Market Size and Forecast, 2022-2032 ($Million)
6.4.2. Market Size and Forecast, by Region, 2022-2032 ($Million)

Chapter 7. Immunohistochemistry (IHC) Market by End-User
7.1. Market Overview
7.2. Hospitals & Diagnostic Laboratories
7.2.1. Market Size and Forecast, 2022-2032 ($Million)
7.2.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
7.3. Academic & research Institutes
7.3.1. Market Size and Forecast, 2022-2032 ($Million)
7.3.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
7.4. Others
7.4.1. Market Size and Forecast, 2022-2032 ($Million)
7.4.2. Market Size and Forecast, by Region, 2022-2032 ($Million)

Chapter 8. Immunohistochemistry (IHC) Market, by Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. North America Immunohistochemistry (IHC) Market Size and Forecast by Product, 2022-2032, ($Million)
8.2.3. North America Immunohistochemistry (IHC) Market Size and Forecast by Application, 2022-2032, ($Million)
8.2.4. North America Immunohistochemistry (IHC) Market Size and Forecast by End-User, 2022-2032, ($Million)
8.2.5. North America Immunohistochemistry (IHC) Market Size and Forecast by Country, 2022-2032, ($Million)
8.2.6. The U.S.
8.2.6.1. The U.S. Immunohistochemistry (IHC) Market Size and Forecast by Product, 2022-2032, ($Million)
8.2.6.2. The U.S. Immunohistochemistry (IHC) Market Size and Forecast by Application, 2022-2032, ($Million)
8.2.6.3. The U.S. Immunohistochemistry (IHC) Market Size and Forecast by End-User, 2022-2032, ($Million)
8.2.7. Canada
8.2.7.1. Canada Immunohistochemistry (IHC) Market Size and Forecast by Product, 2022-2032, ($Million)
8.2.7.2. Canada Immunohistochemistry (IHC) Market Size and Forecast by Application, 2022-2032, ($Million)
8.2.7.3. Canada Immunohistochemistry (IHC) Market Size and Forecast by End-User, 2022-2032, ($Million)
8.2.8. Mexico
8.2.8.1. Mexico Immunohistochemistry (IHC) Market Size and Forecast by Product, 2022-2032, ($Million)
8.2.8.2. Mexico Immunohistochemistry (IHC) Market Size and Forecast by Application, 2022-2032, ($Million)
8.2.8.3. Mexico Immunohistochemistry (IHC) Market Size and Forecast by End-User, 2022-2032, ($Million)
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Europe Immunohistochemistry (IHC) Market Size and Forecast by Product, 2022-2032, ($Million)
8.3.3. Europe Immunohistochemistry (IHC) Market Size and Forecast by Application, 2022-2032, ($Million)
8.3.4. Europe Immunohistochemistry (IHC) Market Size and Forecast by End-User, 2022-2032, ($Million)
8.3.5. Europe Immunohistochemistry (IHC) Market Size and Forecast by Country, 2022-2032, ($Million)
8.3.6. Germany
8.3.6.1. Germany Immunohistochemistry (IHC) Market Size and Forecast by Product, 2022-2032, ($Million)
8.3.6.2. Germany Immunohistochemistry (IHC) Market Size and Forecast by Application, 2022-2032, ($Million)
8.3.6.3. Germany Immunohistochemistry (IHC) Market Size and Forecast by End-User, 2022-2032, ($Million)
8.3.7. France
8.3.7.1. France Immunohistochemistry (IHC) Market Size and Forecast by Product, 2022-2032, ($Million)
8.3.7.2. France Immunohistochemistry (IHC) Market Size and Forecast by Application, 2022-2032, ($Million)
8.3.7.3. France Immunohistochemistry (IHC) Market Size and Forecast by End-User, 2022-2032, ($Million)
8.3.8. U.K.
8.3.8.1. U.K. Immunohistochemistry (IHC) Market Size and Forecast by Product, 2022-2032, ($Million)
8.3.8.2. U.K. Immunohistochemistry (IHC) Market Size and Forecast by Application, 2022-2032, ($Million)
8.3.8.3. U.K. Immunohistochemistry (IHC) Market Size and Forecast by End-User, 2022-2032, ($Million)
8.3.9. Spain
8.3.9.1. Spain Immunohistochemistry (IHC) Market Size and Forecast by Product, 2022-2032, ($Million)
8.3.9.2. Spain Immunohistochemistry (IHC) Market Size and Forecast by Application, 2022-2032, ($Million)
8.3.9.3. Spain Immunohistochemistry (IHC) Market Size and Forecast by End-User, 2022-2032, ($Million)
8.3.10. Italy
8.3.10.1. Italy Immunohistochemistry (IHC) Market Size and Forecast by Product, 2022-2032, ($Million)
8.3.10.2. Italy Immunohistochemistry (IHC) Market Size and Forecast by Application, 2022-2032, ($Million)
8.3.10.3. Italy Immunohistochemistry (IHC) Market Size and Forecast by End-User, 2022-2032, ($Million)
8.3.11. Rest of Europe
8.3.11.1. Rest of Europe Immunohistochemistry (IHC) Market Size and Forecast by Product, 2022-2032, ($Million)
8.3.11.2. Rest of Europe Immunohistochemistry (IHC) Market Size and Forecast by Application, 2022-2032, ($Million)
8.3.11.3. Rest of Europe Immunohistochemistry (IHC) Market Size and Forecast by End-User, 2022-2032, ($Million)
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Asia-Pacific Immunohistochemistry (IHC) Market Size and Forecast by Country, 2022-2032, ($Million)
8.4.3. Asia-Pacific Immunohistochemistry (IHC) Market Size and Forecast by Application, 2022-2032, ($Million)
8.4.4. Asia-Pacific Immunohistochemistry (IHC) Market Size and Forecast by Product, 2022-2032, ($Million)
8.4.5. Asia-Pacific Immunohistochemistry (IHC) Market Size and Forecast by End-User, 2022-2032, ($Million)
8.4.6. China
8.4.6.1. China Immunohistochemistry (IHC) Market Size and Forecast by Product, 2022-2032, ($Million)
8.4.6.2. China Immunohistochemistry (IHC) Market Size and Forecast by Application, 2022-2032, ($Million)
8.4.6.3. China Immunohistochemistry (IHC) Market Size and Forecast by End-User, 2022-2032, ($Million)
8.4.7. India
8.4.7.1. India Immunohistochemistry (IHC) Market Size and Forecast by Product, 2022-2032, ($Million)
8.4.7.2. India Immunohistochemistry (IHC) Market Size and Forecast by Application, 2022-2032, ($Million)
8.4.7.3. India Immunohistochemistry (IHC) Market Size and Forecast by End-User, 2022-2032, ($Million)
8.4.8. Japan
8.4.8.1. Japan Immunohistochemistry (IHC) Market Size and Forecast by Product, 2022-2032, ($Million)
8.4.8.2. Japan Immunohistochemistry (IHC) Market Size and Forecast by Application, 2022-2032, ($Million)
8.4.8.3. Japan Immunohistochemistry (IHC) Market Size and Forecast by End-User, 2022-2032, ($Million)
8.4.9. South Korea
8.4.9.1. South Korea Immunohistochemistry (IHC) Market Size and Forecast by Product, 2022-2032, ($Million)
8.4.9.2. South Korea Immunohistochemistry (IHC) Market Size and Forecast by Application, 2022-2032, ($Million)
8.4.9.3. South Korea Immunohistochemistry (IHC) Market Size and Forecast by End-User, 2022-2032, ($Million)
8.4.10. Rest of APAC
8.4.10.1. Rest of APAC Immunohistochemistry (IHC) Market Size and Forecast by Product, 2022-2032, ($Million)
8.4.10.2. Rest of APAC Immunohistochemistry (IHC) Market Size and Forecast by Application, 2022-2032, ($Million)
8.4.10.3. Rest of APAC Immunohistochemistry (IHC) Market Size and Forecast by End-User, 2022-2032, ($Million)
8.5. Rest of the World
8.5.1. Key Market Trends and Opportunities
8.5.2. Rest of the World Immunohistochemistry (IHC) Market Size and Forecast by Product, 2022-2032, ($Million)
8.5.3. Rest of the World Immunohistochemistry (IHC) Market Size and Forecast by Application, 2022-2032, ($Million)
8.5.4. Rest of the World Immunohistochemistry (IHC) Market Size and Forecast by End-User, 2022-2032, ($Million)
8.5.5. Rest of the World Immunohistochemistry (IHC) Market Size and Forecast by Country, 2022-2032, ($Million)
8.5.6. Latin America
8.5.6.1. Latin America Immunohistochemistry (IHC) Market Size and Forecast by Product, 2022-2032, ($Million)
8.5.6.2. Latin America Immunohistochemistry (IHC) Market Size and Forecast by Application, 2022-2032, ($Million)
8.5.6.3. Latin America Immunohistochemistry (IHC) Market Size and Forecast by End-User, 2022-2032, ($Million)
8.5.7. Middle East
8.5.7.1. Middle East Immunohistochemistry (IHC) Market Size and Forecast by Product, 2022-2032, ($Million)
8.5.7.2. Middle East Immunohistochemistry (IHC) Market Size and Forecast by Application, 2022-2032, ($Million)
8.5.7.3. Middle East Immunohistochemistry (IHC) Market Size and Forecast by End-User, 2022-2032, ($Million)
8.5.8. Africa
8.5.8.1. Africa Immunohistochemistry (IHC) Market Size and Forecast by Product, 2022-2032, ($Million)
8.5.8.2. Africa Immunohistochemistry (IHC) Market Size and Forecast by Application, 2022-2032, ($Million)
8.5.8.3. Africa Immunohistochemistry (IHC) Market Size and Forecast by End-User, 2022-2032, ($Million)

Chapter 9. Competitive Landscape
9.1. Market Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Developmental Strategy Benchmarking
9.3.1. New Product Development
9.3.2. Product Launches
9.3.3. Business Expansions
9.3.4. Partnerships, Joint Ventures, and Collaborations
9.3.5. Mergers and Acquisitions

Chapter 10. Company Profiles
10.1. F. Hoffman-La Roche AG
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis
10.2. Danaher Corporation
10.2.1. Company Snapshot
10.2.2. Financial Performance
10.2.3. Product offerings
10.2.4. Key Strategic Initiatives
10.2.5. SWOT Analysis
10.3. Agilent Technologies, Inc.
10.3.1. Company Snapshot
10.3.2. Financial Performance
10.3.3. Product offerings
10.3.4. Key Strategic Initiatives
10.3.5. SWOT Analysis
10.4. Merck KGaA
10.4.1. Company Snapshot
10.4.2. Financial Performance
10.4.3. Product offerings
10.4.4. Key Strategic Initiatives
10.4.5. SWOT Analysis
10.5. Bio-Rad Laboratories, Inc.
10.5.1. Company Snapshot
10.5.2. Financial Performance
10.5.3. Product offerings
10.5.4. Key Strategic Initiatives
10.5.5. SWOT Analysis
10.6. Bio-Techne Corporation
10.6.1. Company Snapshot
10.6.2. Financial Performance
10.6.3. Product offerings
10.6.4. Key Strategic Initiatives
10.6.5. SWOT Analysis
10.7. Abcam plc
10.7.1. Company Snapshot
10.7.2. Financial Performance
10.7.3. Product offerings
10.7.4. Key Strategic Initiatives
10.7.5. SWOT Analysis
10.8. Dickinson and Company
10.8.1. Company Snapshot
10.8.2. Financial Performance
10.8.3. Product offerings
10.8.4. Key Strategic Initiatives
10.8.5. SWOT Analysis
10.9. PerkinElmer, Inc.
10.9.1. Company Snapshot
10.9.2. Financial Performance
10.9.3. Product offerings
10.9.4. Key Strategic Initiatives
10.9.5. SWOT Analysis
10.10. PerkinElmer, Inc.
10.10.1. Company Snapshot
10.10.2. Financial Performance
10.10.3. Product offerings
10.10.4. Key Strategic Initiatives
10.10.5. SWOT Analysis

*The list of companies is subject to change during the final compilation of the report

 

Key Players
  • F. Hoffman-La Roche AG
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Abcam plc
  • Dickinson and Company
  • PerkinElmer, Inc.
  • Takara Bio, Inc.
Market Segments

By Product

  • Antibodies
  • Reagents
  • Equipment
  • Kits

By Application

  • Diagnostic application
  • Research application
  • Forensic applications

By End-user

  • Hospitals & Diagnostic Laboratories
  • Academic & Research Institutes
  • Other

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • Middle East
    • Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

Injectable contraceptive is a form of birth control…
The global small intestinal bacterial overgrowth diagnostics market…
Insomnia is a sleep disorder that is characterized…
Progressive Supranuclear Palsy is a rare neurodegenerative disease…
Pancreatic cancer arises when cells in the pancreas…
Healthcare analytical testing services are a type of…
Traumatic Brain Injury (TBI) is a disruption in…
The Hormone Replacement Therapy Market was valued at…
Critical limb ischemia is a serious form of…
Acute coronary syndrome is a term for a…